Ambarish Pandey
University of Texas Southwestern Medical Center · UT Southwestern
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
7
all conditions, ClinicalTrials.gov
NIH grants tied to them
7
NIH RePORTER
Trial papers
155
PubMed author-name match
Trials
Studies that name Ambarish Pandey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:46 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06593314 · Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 DiabetesUniversity of Texas Southwestern Medical Center · recruiting · Heart Failure, Diabetes · principal investigator
- Ph1/Ph2NCT06143566 · Polypill for Prevention of CardiomyopathyUniversity of Texas Southwestern Medical Center · recruiting · Type 2 Diabetes, High Blood Pressure · principal investigator
- Ph2NCT06130059 · Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and InflammationUniversity of Texas Southwestern Medical Center · recruiting · Heart Failure, Inflammation · principal investigator
- N/ANCT06115369 · Food Supplementation Delivered Conditionally vs Not Among Patients With Heart FailureUniversity of Texas Southwestern Medical Center · completed · Heart Failure · principal investigator
- N/ANCT05928026 · Financial Support in an Underserved and Low-Income Population With Heart FailureUniversity of Texas Southwestern Medical Center · completed · Heart Failure, Systolic, Financial Stress, Medication Adherence · principal investigator
- Ph2NCT05528588 · Furoscix in Heart Failure Patients With Diuretic ResistanceUniversity of Texas Southwestern Medical Center · completed · Heart Failure · principal investigator
- Ph2NCT05514938 · Polypill in Acute Coronary SyndromeUniversity of Texas Southwestern Medical Center · completed · Acute Coronary Syndrome, Lipid Disorder, Coronary Artery Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Leveraging Telemedicine to Improve guideline-directed Medical Therapy Use and Outcomes Among Rural Patients with Heart Failure- the RURAL-HF TrialR01MD021645 · NIMHD · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $834,657 awarded in 2026Same name and institution; not confirmed by an ID
- MUlti-dimensional taiLored Telehealth Intervention for HFpEF (MULTI-HFpEF)R01AG101938 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $799,870 awarded in 2026Same name and institution; not confirmed by an ID
- Polypill strategy for the treatment of patients after acute coronary syndromes - A multicenter randomized controlled trialR01HL173838 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2025 to 2026 · $668,630 awarded in 2026Same name and institution; not confirmed by an ID
- Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient populationR01MD017529 · NIMHD · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2022 to 2025 · $735,237 awarded in 2025Same name and institution; not confirmed by an ID
- The University of Texas Medical Student Training on Aging Research (UT-MSTAR) ProgramT35AG092747 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2025 · $135,286 awarded in 2025Same name and institution; not confirmed by an ID
- Cardiac biomarkers, intensive blood pressure treatment and risk of adverse cardiovascular outcomes in type 2 diabetes, a secondary analysis of the ACCORD BPR21HL169708 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2023 to 2024 · $124,885 awarded in 2024Same name and institution; not confirmed by an ID
- Evaluation of Racial Differences in Cardiorespiratory Fitness Decline with Aging & Underlying Biological MechanismsR03AG067960 · NIA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2020 to 2021 · $163,875 awarded in 2021Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:46 UTC. The ranking covers the 200 most relevant of 155 PubMed records, and a shared surname and initials can bring in a namesake. All 155 on PubMed
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.N Engl J Med · 2021753 citationsRCR 43.8
- 273 citationsRCR 12.5
- Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.Lancet Diabetes Endocrinol · 2021177 citationsRCR 10.9
- Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.J Gastroenterol Hepatol · 2006154 citationsRCR 4.1
- 141 citationsRCR 11.7
- The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration.J Proteomics · 2013136 citationsRCR 5.6
- Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis.J Proteomics · 2013120 citationsRCR 4.6
- Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.Cell Rep · 2019119 citationsRCR 4.6
- 100 citationsRCR 4.6
- 97 citationsRCR 6.3